Taking levetiracetam three times daily for epilepsy
Treatments studied
Part of Brain & nervous system clinical trials.
This trial is for adults with uncontrolled epilepsy who have been taking a high dose of Levetiracetam alone for at least a year. It tests whether taking Levetiracetam three times a day works better than the usual schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have epilepsy that is not fully controlled (at least one seizure in the last 6 months).
- You are taking only Levetiracetam (no other seizure medicines).
- You have been on Levetiracetam for at least 12 months.
- Your current daily dose of Levetiracetam is between 1.5 and 3 grams.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how levetiracetam (a seizure medicine) affects blood cell counts in adults with epilepsy. If you have been taking only levetiracetam for at least 6 months, the study will check your blood levels to see if there are any changes.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This trial tests if levetiracetam, a seizure medication, can prevent seizures in adults with Down syndrome who also have Alzheimer's disease. It aims to help manage a common complication and improve quality of life.
This trial looks at how safe brivaracetam is and how well it can be used in children and teens with certain types of epilepsy that are not well controlled. It may help families who are dealing with frequent focal seizures despite taking seizure medicines.
This study looks back at children who had a prolonged seizure (status epilepticus) and needed a second medicine after the first one didn't work. Doctors want to see how well levetiracetam works compared to phenytoin, so they can choose better treatments for future children.
This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.